Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled 14C material in advanced cancer patients - Concepedia

Concepedia

Publication | Closed Access

Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled 14C material in advanced cancer patients

56

Citations

10

References

2012

Year

Sally Clive, Margaret M. Woo, Thomas Nydam, Lindsay Kelly, Margaret Squier, Mark Kagan

Cancer Chemotherapy and Pharmacology

OncologyPancreatic CancerMedicineAdvanced Cancer PatientsActive Pan-deacetylase InhibitorPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1